Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Lancet Respir Med. 2014 May 19;2(8):611–620. doi: 10.1016/S2213-2600(14)70097-9

Table 2.

Comparison of Key Biomarker Values (Pre-Randomization) Between ARMA and ALVEOLI Cohorts

Biomarker* ARMA Cohort ALVEOLI Cohort p-value
Protein C (% control) 47 (32–66) 78 (45–122) < .001
Plasminogen activator inhibitor-1 (ng/ml) 70 (40–138) 61 (30–144) .002
Interleukin-6 (pg/ml) 264 (109–766) 238 (93–741) .26
Interleukin-8 (pg/ml) 43 (20–93) 40 (16–98) 0.001
Soluble tumor necrosis factor receptor-I (pg/ml) 3255 (2128–5600) 4265 (2599–8448) < .001
Soluble intercellular adhesion molecule-1 (ng/ml) 627 (345–1038) 924 (605–1385) < .001
Surfactant Protein D (ng/ml) 84 (40–162) 101 (50–218) .004
Von Willebrand Factor antigen (% control) 284 (173–436) 398 (247–624) < .001
*

Data shown as median (interquartile range)